Thursday , April 22 2021
Home / HEADLINES / INDIA / COVAXIN clinical trials cross 13,000 subjects, half way mark and forges ahead, India’s largest Phase III trials

COVAXIN clinical trials cross 13,000 subjects, half way mark and forges ahead, India’s largest Phase III trials

Please share this news